Clinical Trial Update: Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study [Phase 2]

View source ↗

Summary

Phase 2 safety and feasibility study evaluating imatinib as a treatment for cervical spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spinal Cord Injury

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Professor Mikael Svensson, MD PhD | Conditions: Cervical Spinal Cord Injury | Phase 2 | Status: UNKNOWN